Brookline Capital Markets initiated coverage of Medicus Pharma (NASDAQ:MDCX) with a buy rating, citing the potential of its basal cell carcinoma treatment D-MNA. The investment firm noted that D ...

Medicus Pharma Ltd (MDCX) has received a new Buy rating, initiated by Brookline Capital Markets analyst, Kumaraguru Raja. Discover the latest stocks recommended by top Wall Street analysts ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

CHEB.WSChenghe Acquisition II Co. Chenghe Acquisition II Co. SBXD.WSSilverBox Corp IV WT EXP 081929 SilverBox Corp IV WT EXP 081929 AAM.WSAA Mission Acquisition Corp. WT EXP 080131 AA Mission ...

Reveal insider sentiment with alternative data that tracks buy and sell trades made by top managers and company directors.

In response, Medicus Healthcare Solutions, a leading interim healthcare staffing agency, has released its 2025 Market Trend Report: Examining the Oncologist Shortage. This detailed report sheds ...

ALPHARETTA, Ga., Jan. 13, 2025 /PRNewswire/ -- Medicus IT, a leading Healthcare Solutions Provider (HSP) today announced the appointment of John Carter as its Chief Operations Officer (COO). Carter ...

Medicus Pharma Ltd is listed on the CBOE trading with ticker code MDCXW.US. It has a market capitalisation of -, with approximately 0.00 shares in issue. Over the last year, Medicus Pharma Ltd ...

And highest quality companies can see their share prices grow by huge amounts. Don't believe it? Then look at the Pro Medicus Limited (ASX:PME) share price. It's 934% higher than it was five years ago ...

Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.